GDTC
CytoMed Therapeutics Ltd
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.06
-0.01 ▼ -0.93%
🌙 3월 13일 5:20 PM ET (한국 3/14 06:20)
$1.04
-0.02 ▼ -1.89%
| Index | - | P/E | - | EPS (ttm) | -0.24 | Insider Own | 65.58% | Shs Outstand | 0.01B | Perf Week | 0.95% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.00B | Perf Month | 1.92% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | - | Inst Own | 0.45% | Short Float | 3.4% | Perf Quarter | -31.93% |
| Income | -0.00B | P/S | 73.18 | EPS this Y | - | Inst Trans | 11.96% | Short Ratio | 0.23 | Perf Half Y | -47.26% |
| Sales | 0.00B | P/B | 2.18 | EPS next 5Y | - | ROA | -37.94% | Short Interest | 0.14M | Perf YTD | -20.6% |
| Book/sh | 0.49 | P/C | 5.55 | EPS past 3/5Y | -588.52% -290.76% | ROE | -42.29% | 52W High | -71.2% ($3.68) | Perf Year | -60.3% |
| Cash/sh | 0.19 | P/FCF | - | Sales past 3/5Y | - | ROIC | -46.59% | 52W Low | 45.56% ($0.73) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -21.99% | Gross Margin | - | Volatility(W/M) | 6.89% 7.09% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 62.59 | Sales Y/Y TTM | - | Oper. Margin | -1740.21% | ATR (14) | 0.08 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 5.81 | EPS Q/Q | -109.86% | Profit Margin | -1629% | RSI (14) | 49.85 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.81 | Sales Q/Q | - | SMA20 | 0.67% ($1.05) | Beta | -0.33 | Target Price | $5 |
| Payout | - | Debt/Eq | 0.07 | Earnings | - | SMA50 | -0.07% ($1.06) | Rel Volume | 0.01 | Prev Close | $1.07 |
| Employees | 43 | LT Debt/Eq | 0.06 | EPS/Sales Surpr. | - | SMA200 | -39.72% ($1.76) | Avg Volume(3M) | 0.60M | Price | $1.06 |
| IPO | 2023/4/14 | Option/Short | No/Yes | Trades | 42 | Volume | 4,295 | Change | -0.93% |
뉴스 로딩 중...